2026 NPPES data Otolaryngology Physician NPI 1326280009 DO
Verify on CMS →

MARK GINSBURG, DO

Otolaryngology Physician in CHESTER, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
887
Medicare Part D claims · 339 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
50.9015/100
▼ 32 pts below national avg 83.1 · [object Object]
Industry payments
$173.02
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK GINSBURG, DO reported a CMS MIPS final score of 50.9015/100 — below the 83.1 national average — and filed 887 Medicare Part D claims in 2023.

50.9015/100
MIPS score · -32 vs avg
887
Part D claims, 2023
97%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK GINSBURG, DO's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

51 4th percentile higher than 4% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). This entry sits in this band. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK GINSBURG, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK GINSBURG, DO?

Below national average

NPI registry status

Active

Issued 03/27/2009

NPI 1326280009

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

887 74% vs specialty avg

2023 prescription claims

Specialty avg: 509

MIPS final score

50.9015/100 32.198499999999996% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Otolaryngology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Otolaryngology Physician share within Pennsylvania

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within Pennsylvania

Medicare quality performance — MIPS

MARK GINSBURG, DO's 2023 MIPS final score plotted against the Otolaryngology Physician national average

Below national average
MIPS Final Score
50.9015/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngology Physician) — 50.9015/100 vs national avg 83.1

0%100%National avg83%50.9%
MIPS final score (Otolaryngology Physician) — 50.9015/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK GINSBURG, DO appears in the CMS NPPES registry as a Otolaryngology Physician provider holding DO credentials at 2112 PROVIDENCE AVE, CHESTER, PA, 19013, with a listed phone of (610) 874-5366. NPI 1326280009 was issued on 03/27/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GINSBURG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 887 prescription claims written by this provider, covering 339 Medicare beneficiaries and totaling roughly $75K in drug spend, split 3% brand-name and 97% generic by claim count, with an opioid prescribing rate of 4.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 50.9015/100 for the 2023 performance year (Quality 37.0438, Cost 20.28), compared with the national average of 83.1.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2112 PROVIDENCE AVE
CHESTER, PA 19013

Provider Details

NPI 1326280009
Specialty Otolaryngology Physician
Credentials DO
Gender Male
NPI Issued 03/27/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

50.9015
Final Score
Avg: 83.1
37.0438
Quality
20.28
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK GINSBURG, DO bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NOVACARE OUTPATIENT REHABILITATION EAST, INC.
COLLEGEVILLE, PA
PROVIDENCE EAR NOSE AND THROAT ASSOCIATES INC
MEDIA, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK GINSBURG, DO. Source: openpaymentsdata.cms.gov.

Total received

$173

Largest payer

Integra LifeSciences Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MARK GINSBURG, DO. To verify MARK GINSBURG, DO's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK GINSBURG, DO — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 887 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

887
Total Claims
$75K
Total Drug Cost
339
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,161
Total Day Supply
27,458
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$58K
Generic Drug Cost
$17K
Opioid Claims
42 (4.7% rate)
Antibiotic Claims
116

Patient Demographics

Average Patient Age
72.5 years
Avg HCC Risk Score
1.24
Gender Split
61% female / 39% male
Age Distribution
<65: 33, 65-74: 165, 75-84: 102, 85+: 39

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK GINSBURG, DO prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Fluticasone Propionate
228
Famotidine
66
Omeprazole
63
Doxycycline Hyclate
61
Ipratropium Bromide
58
Methylprednisolone
57
Montelukast Sodium
43
Ofloxacin
39
Acetaminophen-Codeine
Acetaminophen With Codeine
31
Prednisone
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How MARK GINSBURG, DO fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

MARK GINSBURG, DO's 887 claims are above the specialty average of 509.

Nearby Otolaryngology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as GINSBURG.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK GINSBURG, DO's specialty?
MARK GINSBURG, DO specializes in Otolaryngology Physician and practices in CHESTER, Pennsylvania. Credentials: DO.
How much does MARK GINSBURG, DO prescribe under Medicare Part D?
In 2023, MARK GINSBURG, DO wrote 887 Medicare Part D claims totaling $75K in drug costs for 339 beneficiaries.
What is MARK GINSBURG, DO's Medicare quality score?
MARK GINSBURG, DO has a CMS MIPS Final Score of 50.9015/100 (Quality: 37.0438, Cost: 20.28). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK GINSBURG, DO located?
MARK GINSBURG, DO is located at 2112 PROVIDENCE AVE, CHESTER, PA, 19013. Phone: (610) 874-5366.
What is MARK GINSBURG, DO's NPI number?
MARK GINSBURG, DO's National Provider Identifier (NPI) is 1326280009, issued on 03/27/2009.
Does MARK GINSBURG, DO prescribe more brand-name or generic drugs?
MARK GINSBURG, DO's prescribing is 3% brand-name and 97% generic drugs by claim count, with $58K in brand drug costs.
Does MARK GINSBURG, DO prescribe opioids?
Yes, MARK GINSBURG, DO had 42 opioid claims in 2023 with an opioid prescribing rate of 4.7%.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does MARK GINSBURG, DO prescribe most often?
Based on 2023 Medicare Part D data, MARK GINSBURG, DO's most frequently prescribed drugs include Fluticasone Propionate, Famotidine, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK GINSBURG, DO accept Medicare?
MARK GINSBURG, DO appears in CMS Medicare data with 887 Part D claims and 339 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK GINSBURG, DO's credentials?
MARK GINSBURG, DO's NPI is 1326280009 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology